Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.9% lower and the iShares Biotechnology ETF (IBB) up 0.3%.
Novartis (NVS) stock was up more than 3% after the company reported Q2 core earnings and net sales that topped analysts' expectations.
Danaher (DHR) shares were down more than 15% even after the company posted higher Q2 adjusted net earnings and sales, and raised its 2026 adjusted EPS guidance.
Agios Pharmaceuticals (AGIO) shares were down more than 12% after the company said it will halt development of its oral medicine, tebapivat, for sickle cell disease after a Phase 2 study failed to demonstrate a distinct clinical profile.